BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg. 1988;75:110-112. [PMID: 3349293 DOI: 10.1002/bjs.1800750206] [Cited by in Crossref: 286] [Cited by in F6Publishing: 249] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Roig-garcía J, Gironés-vilá J, Garsot-savall E, Puig-costa M, Rodríguez-hermosa J, Codina-cazador A. Gastrectomía por laparoscopia en el cáncer gástrico. Experiencia en una serie de 56 pacientes. Cirugía Española 2008;83:65-70. [DOI: 10.1016/s0009-739x(08)70508-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
2 Shen DF, Chen DW, Quan ZW, Dong P, Wang XF, Xu HZ, Zhao ML, Chen L. Dissection of No. 13 lymph node in radical gastrectomy for gastric carcinoma. World J Gastroenterol 2008; 14(6): 936-938 [PMID: 18240353 DOI: 10.3748/wjg.14.936] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
3 Crookes PF. Gastric cancer. Clin Obstet Gynecol 2002;45:892-903. [PMID: 12370631 DOI: 10.1097/00003081-200209000-00036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
4 Harrison LE, Karpeh MS, Brennan MF. Total gastrectomy is not necessary for proximal gastric cancer. Surgery. 1998;123:127-130. [PMID: 9481396 DOI: 10.1016/s0039-6060(98)70248-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
5 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
6 Kasakura Y, Mochizuki F, Wakabayashi K, Kochi M, Fujii M, Takayama T. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res. 2002;103:252-259. [PMID: 11922742 DOI: 10.1006/jsre.2002.6368] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
7 Moreno González E. Treatment of gastric cancer. Cancer Treat Res 1991;55:171-204. [PMID: 1681857 DOI: 10.1007/978-1-4615-3882-0_11] [Reference Citation Analysis]
8 Yang SH, Zhang YC, Yang KH, Li YP, He XD, Tian JH, Lv TH, Hui YH, Sharma N. An evidence-based medicine review of lymphadenectomy extent for gastric cancer. Am J Surg. 2009;197:246-251. [PMID: 18722583 DOI: 10.1016/j.amjsurg.2008.05.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
9 Omloo J, Law S, Launois B, Le Prisé E, Wong J, van Berge Henegouwen M, van Lanschot J. Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection. European Journal of Surgical Oncology (EJSO) 2009;35:793-7. [DOI: 10.1016/j.ejso.2008.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
10 Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995;345:745-748. [PMID: 7891484 DOI: 10.1016/s0140-6736(95)90637-1] [Cited by in Crossref: 734] [Cited by in F6Publishing: 226] [Article Influence: 27.2] [Reference Citation Analysis]
11 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
12 Davis PA, Sano T. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? Crit Rev Oncol Hematol. 2001;40:77-94. [PMID: 11578917 DOI: 10.1016/s1040-8428(00)00131-1] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
13 Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc. 2010;24:304-334. [PMID: 19572178 DOI: 10.1007/s00464-009-0583-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
14 Peeters KC, Hundahl SA, Kranenbarg EK, Hartgrink H, van de Velde CJ. Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial. World J Surg. 2005;29:1576-1584. [PMID: 16317484 DOI: 10.1007/s00268-005-7907-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
15 Siewert JR, Böttcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993;80:1015-1018. [PMID: 8402053 DOI: 10.1002/bjs.1800800829] [Cited by in Crossref: 306] [Cited by in F6Publishing: 266] [Article Influence: 10.6] [Reference Citation Analysis]
16 Jiang L, Yang KH, Guan QL, Zhao P, Chen Y, Tian JH. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis. J Surg Oncol. 2013;107:807-814. [PMID: 23512524 DOI: 10.1002/jso.23325] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
17 Noguchi M. Is the value of regional lymph node dissection different in Breast Cancer ana Gastrointestinal Cancer? Breast Cancer 1999;6:171-4. [DOI: 10.1007/bf02967163] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
18 Hundahl SA. Surgery for gastric cancer: what the trials indicate. Surg Oncol Clin N Am 2012;21:79-97. [PMID: 22098833 DOI: 10.1016/j.soc.2011.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Enzinger PC, Benedetti JK, Meyerhardt JA, McCoy S, Hundahl SA, Macdonald JS, Fuchs CS. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245:426-434. [PMID: 17435550 DOI: 10.1097/01.sla.0000245469.35088.42] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
20 Orhan O, Eroglu C, Kaplan B, Ucar K, Altinbas M, Ozkan M, Unal D, Yildiz OG, Soyuer S. Whole abdominal field versus standard field radiotherapy plus concomitant and adjuvant chemotherapy for patients with locally advanced gastric cancer. J Radiat Res 2011;52:168-75. [PMID: 21343682 DOI: 10.1269/jrr.10075] [Reference Citation Analysis]
21 Di Leo A, Marrelli D, Roviello F, Bernini M, Minicozzi A, Giacopuzzi S, Pedrazzani C, Baiocchi LG, de Manzoni G. Lymph node involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg. 2007;11:1146-1153. [PMID: 17576611 DOI: 10.1007/s11605-006-0062-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
22 Thompson GB, van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet. 1993;342:713-718. [PMID: 8103825 DOI: 10.1016/0140-6736(93)91711-t] [Cited by in Crossref: 48] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
23 Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K. Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery. 2002;131:S85-S91. [PMID: 11821792 DOI: 10.1067/msy.2002.119309] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
24 Kassam Z, Lockwood G, O'brien C, Brierley J, Swallow C, Oza A, Siu L, Knox JJ, Wong R, Cummings B, Kim J, Moore M, Ringash J. Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases. Int J Radiat Oncol Biol Phys 2006;65:713-9. [PMID: 16626887 DOI: 10.1016/j.ijrobp.2006.01.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
25 Bollschweiler E, Boettcher K, Hoelscher AH, Sasako M, Kinoshita T, Maruyama K, Siewert JR. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg. 1992;79:156-160. [PMID: 1555065 DOI: 10.1002/bjs.1800790221] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 2.6] [Reference Citation Analysis]
26 Sauvanet A, Msika S. [Gastric antrum cancer: what intervention?]. Ann Chir 2005;130:483-6. [PMID: 16023610 DOI: 10.1016/j.anchir.2005.06.002] [Reference Citation Analysis]
27 Msika S, Kianmanesh R. Le traitement du cancer gastrique. Chirurgie 1999;124:560-7. [DOI: 10.1016/s0001-4001(00)88281-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
28 Borie F, Plaisant N, Millat B, Hay JM, Fagniez PL. Appropriate gastric resection with lymph node dissection for early gastric cancer. Ann Surg Oncol. 2004;11:512-517. [PMID: 15078634 DOI: 10.1245/ASO.2004.06.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
29 Khushalani NI. Cancer of the Esophagus and Stomach. Mayo Clinic Proceedings 2008;83:712-22. [DOI: 10.1016/s0025-6196(11)60900-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
30 van de Velde CJ. Current role of surgery and multimodal treatment in localized gastric cancer. Ann Oncol 2008;19 Suppl 5:v93-8. [PMID: 18611909 DOI: 10.1093/annonc/mdn319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
32 Sierra A, Regueira FM, Hernández-Lizoáin JL, Pardo F, Martínez-Gonzalez MA, A-Cienfuegos J. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol. 2003;10:219-226. [PMID: 12679305 DOI: 10.1245/aso.2003.07.009] [Cited by in Crossref: 67] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
33 Maehara Y, Okuyama T, Moriguchi S, Orita H, Kusumoto H, Korenaga D, Sugimachi K. Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. Cancer 1992;70:392-5. [PMID: 1617589 DOI: 10.1002/1097-0142(19920715)70:2<392::aid-cncr2820700204>3.0.co;2-p] [Cited by in Crossref: 43] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
34 Batista TP, Martins MR. Lymph node dissection for gastric cancer: a critical review. Oncol Rev 2012;6:e12. [PMID: 25992202 DOI: 10.4081/oncol.2012.e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Fujino Y, Nagata Y, Ogino K, Watahiki H. Evaluation of endoscopic ultrasonography as an indicator for surgical treatment of gastric cancer. J Gastroenterol Hepatol. 1999;14:540-546. [PMID: 10385062 DOI: 10.1046/j.1440-1746.1999.01912.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
36 Saito A, Korenaga D, Maehara Y, Baba H, Okamura T, Sugimachi K. In vitro succinate dehydrogenase chemosensitivity of gastric carcinoma?relationship to DNA content. Cancer Chemother Pharmacol 1992;29:185-9. [DOI: 10.1007/bf00686250] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
37 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B. Extended lymph node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol. 2006;93:394-400. [PMID: 16550575 DOI: 10.1002/jso.20495] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
38 Bremers AJ, Rutgers EJ, van de Velde CJ. Cancer surgery: the last 25 years. Cancer Treat Rev. 1999;25:333-353. [PMID: 10644500 DOI: 10.1053/ctrv.1999.0147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
39 Cohen MM, Zoeter MA, Loar C. Survival following surgical treatment of gastric cancer: A challenge for the community endoscopist. Surg Endosc 1994;8:862-6. [DOI: 10.1007/bf00843455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues JJ. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2012;1:CD001964. [PMID: 22258947 DOI: 10.1002/14651858.cd001964.pub3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
41 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
42 Hundahl SA. Eliminating and suppressing local-regional disease in gastric cancer. J Surg Oncol 2005;90:171-3. [DOI: 10.1002/jso.20224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
43 Kosaka T, Ueshige N, Sugaya J, Nakano Y, Akiyama T, Tomita F, Saito H, Kita I, Takashima S. Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today. 1999;29:695-700. [PMID: 10483741 DOI: 10.1007/bf02482311] [Cited by in Crossref: 57] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
44 Songun I, van de Velde CJ. Results of completed clinical trials for gastric cancer. Eur J Surg Oncol 1995;21:588-90. [PMID: 8631398 DOI: 10.1016/s0748-7983(95)94918-6] [Reference Citation Analysis]
45 Hughes BGM, Yip D, Chao M, Gibbs P, Carroll S, Goldstein D, Burmeister B, Karapetis C. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg 2004;74:951-6. [DOI: 10.1111/j.1445-1433.2004.03218.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
46 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
47 Ikeda Y, Haraguchi Y, Mori M, Kajiyama K, Yamagata M, Adachi Y, Sugimachi K. Gastric cancer in a general hospital in Japan. Semin Surg Oncol 1994;10:150-5. [PMID: 8052786 DOI: 10.1002/ssu.2980100218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
48 Macintyre IMC, Akoh JA. Improving survival in gastric cancer: Review of operative mortality in english language publications from 1970. British Journal of Surgery 1991;78:771-6. [DOI: 10.1002/bjs.1800780703] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
49 Nakajima T, Nishi M, Kajitani T. Improvement in treatment results of gastric cancer with surgery and chemotherapy: Experience of 9,700 cases in the cancer institute hospital, Tokyo. Semin Surg Oncol 1991;7:365-72. [DOI: 10.1002/ssu.2980070608] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
50 Lehnert T. Tailored lymphadenectomy for gastric cancer? Ann Surg Oncol 1998;5:563-4. [PMID: 9831098 DOI: 10.1007/BF02303819] [Reference Citation Analysis]
51 Kern KA. Natural history of surgically treated gastric cancer. Cancer Treat Res 1991;55:1-16. [PMID: 1681850 DOI: 10.1007/978-1-4615-3882-0_1] [Reference Citation Analysis]
52 Peixoto RD, Rocha-Filho DR, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Filho RPDP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Jr UR, Jesus VHF, Jr WLC, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer. Ecancermedicalscience 2020;14:1126. [PMID: 33209117 DOI: 10.3332/ecancer.2020.1126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Schmidt-matthiesen A. Do patients really benefit from the extended lymph node dissection for gastric carcinoma Contra:. European Journal of Cancer 1998;34:1483-6. [DOI: 10.1016/s0959-8049(98)00202-0] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
54 Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close!. World J Gastroenterol 2015; 21(41): 11609-11620 [PMID: 26556990 DOI: 10.3748/wjg.v21.i41.11609] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
55 Patel SH, Kooby DA. Gastric adenocarcinoma surgery and adjuvant therapy. Surg Clin North Am 2011;91:1039-77. [PMID: 21889029 DOI: 10.1016/j.suc.2011.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
56 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol. 2005;54:209-241. [PMID: 15890270 DOI: 10.1016/j.critrevonc.2005.01.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.3] [Reference Citation Analysis]
57 Kundel Y, Levitt ML, Oberman B, Sadezki S, Tichler T, Symon Z, Catane R, Pfeffer R, Brenner B. Adjuvant Chemotherapy and Whole Abdominal Irradiation for Gastric Carcinoma. Tumori 2008;94:469-73. [DOI: 10.1177/030089160809400405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
58 Kang JH, Ryu SY, Jung MR, Jeong O. Comparison of long term survival outcomes between D1+ and D2 lymph node dissection for ≥ pT2 or pN+ gastric carcinoma: A large scale case-control study using propensity score matching. Eur J Surg Oncol 2020;46:1239-46. [PMID: 32331983 DOI: 10.1016/j.ejso.2020.04.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol. 2003;46:59-100. [PMID: 12672518 DOI: 10.1016/S1040-8428(02)00160-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
60 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
61 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
62 Gunderson LL, Tepper JE, Calvo FA, Callister MD. Gastric/GE Junction Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 903-33. [DOI: 10.1016/b978-1-4377-1637-5.00045-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
63 Foo M, Crosby T, Rackley T, Leong T. Role of (chemo)-radiotherapy in resectable gastric cancer. Clin Oncol (R Coll Radiol). 2014;26:541-550. [PMID: 24996375 DOI: 10.1016/j.clon.2014.06.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
64 Harrison LE, Karpeh MS, Brennan MF. Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg. 1998;2:126-131. [PMID: 9834407 DOI: 10.1016/s1091-255x(98)80002-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
65 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
66 Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069-2077. [PMID: 15082726 DOI: 10.1200/jco.2004.08.026] [Cited by in Crossref: 617] [Cited by in F6Publishing: 261] [Article Influence: 34.3] [Reference Citation Analysis]
67 Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease--part II. Curr Probl Surg 2005;42:796-862. [PMID: 16344044 DOI: 10.1067/j.cpsurg.2005.08.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Songun I, Velde CJ. Can Surgical Treatment Results in Gastric Cancer Be Improved? The Oncologist 1996;1:36-40. [DOI: 10.1634/theoncologist.1-1-36] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Roukos DH. Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999;6:46-56. [PMID: 10030415 DOI: 10.1007/s10434-999-0046-z] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 3.8] [Reference Citation Analysis]
70 Korenaga D, Baba H, Kakeji Y, Orita H, Haraguchi M, Maehara Y, Saku M, Sugimachi K. Comparison of R1 and R2 gastrectomy for gastric cancer in patients over 80 years of age. J Surg Oncol. 1991;48:136-141. [PMID: 1921400 DOI: 10.1002/jso.2930480213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
71 Cady B. Contemporary approaches to gastric carcinoma. Cancer Treat Res 1997;90:239-52. [PMID: 9367087 DOI: 10.1007/978-1-4615-6165-1_13] [Reference Citation Analysis]
72 Kaibara N, Sumi K, Yonekawa M, Ohta M, Makino M, Kimura O, Nishidoi H, Koga S. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? The American Journal of Surgery 1990;159:218-21. [DOI: 10.1016/s0002-9610(05)80265-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
73 Hundahl SA. Gastric Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations. Surgical Oncology Clinics of North America 1996;5:129-44. [DOI: 10.1016/s1055-3207(18)30409-5] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
74 Matsukuma A, Furusawa M, Tomoda H, Seo Y. A clinicopathological study of asymptomatic gastric cancer. Br J Cancer 1996;74:1647-50. [PMID: 8932349 DOI: 10.1038/bjc.1996.603] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
75 Knab LM, Belotte J, Munshi HG, Bentrem DJ. Comparative Effectiveness in Esophagogastric Cancer. In: Bilimoria KY, Minami CA, Mahvi DM, editors. Comparative Effectiveness in Surgical Oncology. Cham: Springer International Publishing; 2015. pp. 121-42. [DOI: 10.1007/978-3-319-12553-4_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 1996;83:156-61. [DOI: 10.1002/bjs.1800830205] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
78 Hundahl SA. Surgical quality in trials of adjuvant cancer therapy. J Surg Oncol 2002;80:177-80. [DOI: 10.1002/jso.10123] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
79 Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, Gunderson LL, Goldman B, Martenson JA, Jessup JM, Stemmermann GN, Blanke CD, Macdonald JS. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol 2012;30:2327-33. [PMID: 22585691 DOI: 10.1200/JCO.2011.36.7136] [Cited by in Crossref: 466] [Cited by in F6Publishing: 253] [Article Influence: 46.6] [Reference Citation Analysis]
80 Meyer HJ, J�hne J, Wilke H. Perspectives of surgery and multimodality treatment in gastric carcinoma. J Cancer Res Clin Oncol 1993;119:384-94. [DOI: 10.1007/bf01218419] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
81 Budisin N, Budisin E, Golubovic A. Early complications following total gastrectomy for gastric cancer. J Surg Oncol 2001;77:35-41. [PMID: 11344481 DOI: 10.1002/jso.1063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
82 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002;236:355-66; discussion 366-8. [PMID: 12192322 DOI: 10.1097/00000658-200209000-00012] [Cited by in Crossref: 562] [Cited by in F6Publishing: 458] [Article Influence: 28.1] [Reference Citation Analysis]
83 Hohenberger P, Gretschel S. Gastric cancer. Lancet. 2003;362:305-315. [PMID: 12892963 DOI: 10.1016/s0140-6736(03)13975-x] [Cited by in Crossref: 430] [Cited by in F6Publishing: 215] [Article Influence: 22.6] [Reference Citation Analysis]
84 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355-366; discussion 366-368. [PMID: 12192322 DOI: 10.1097/01.sla.0000027272.08464.0b] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Archie V, Kauh J, Jones DV, Cruz V, Karpeh MS, Thomas CR. Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol. 2006;57:123-131. [PMID: 16412659 DOI: 10.1016/j.critrevonc.2005.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
86 Baba H, Maehara Y, Takeuchi H, Inutsuka S, Okuyama T, Adachi Y, Akazawa K, Sugimachi K. Effect of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery. 1995;117:165-169. [PMID: 7846620 DOI: 10.1016/S0039-6060(05)80080-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
87 Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005;138:899-904. [PMID: 16291391 DOI: 10.1016/j.surg.2005.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
88 Tsujitani S, Oka S, Saito H, Kondo A, Ikeguchi M, Maeta M, Kaibara N. Less invasive surgery for early gastric cancer based on the low probability of lymph node metastasis. Surgery. 1999;125:148-154. [PMID: 10026747 DOI: 10.1016/s0039-6060(99)70258-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 7] [Article Influence: 4.9] [Reference Citation Analysis]
89 Roukos D, Marcouizos G, Batsis C, Kappas A, Encke A. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1996;224:108-9. [PMID: 8678611 DOI: 10.1097/00000658-199607000-00022] [Reference Citation Analysis]
90 Spanknebel KA, Brennan MF. Is D2 lymphadenectomy for gastric cancer a staging tool or a therapeutic intervention? Surg Oncol Clin N Am. 2002;11:415-30, xii. [PMID: 12424860 DOI: 10.1016/s1055-3207(02)00008-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
91 Gunvén P, Maruyama K, Okabayashi K, Sasako M, Kinoshita T. Non-ominous micrometastases of gastric cancer. British Journal of Surgery 1991;78:352-4. [DOI: 10.1002/bjs.1800780326] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
92 Jin ZX, Ma YY, Wang XY, Li LJ, Zheng ZQ. Treatment selection for gastric cancer with portal hypertension: clinical management. Gastric Cancer. 2014;17:302-309. [PMID: 23812903 DOI: 10.1007/s10120-013-0276-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
93 Vural V, Saylam B, Çomçalı B, Düzgün AP, Özer MV, Coşkun F. D1 versus D2 dissection in gastric carcinoma: Evaluation of postoperative mortality and complications. Ulus Cerrahi Derg 2013;29:1-6. [PMID: 25931833 DOI: 10.5152/UCD.2013.01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
94 Lee JS, Douglass HO Jr. D2 dissection for gastric cancer. Surg Oncol 1997;6:215-25. [PMID: 9775408 DOI: 10.1016/s0960-7404(98)00009-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
95 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
96 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
97 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
98 Ho H, Chang C, Ho W, Liao S, Lin W, Wang C. Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Toxicology and Applied Pharmacology 2013;266:76-85. [DOI: 10.1016/j.taap.2012.10.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
99 El-Sedfy A, Dixon M, Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn NG. Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy. Ann Surg Oncol. 2015;22:1820-1827. [PMID: 25348779 DOI: 10.1245/s10434-014-4168-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
100 Behrns KE, Dalton RR, van Heerden JA, Sarr MC. Extended Lymph Node Dissection for Gastric Cancerd: Is It of Value? Surgical Clinics of North America 1992;72:433-43. [DOI: 10.1016/s0039-6109(16)45688-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
101 Roder JD, Bonenkamp JJ, Craven J, van de Velde CJH, Sasako M, Böttcher K, Stein HJ. Lymphadenectomy for gastric cancer in clinical trials: Update. World J Surg 1995;19:546-53. [DOI: 10.1007/bf00294718] [Cited by in Crossref: 33] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
102 Slagter AE, Vollebergh MA, Jansen EPM, van Sandick JW, Cats A, van Grieken NCT, Verheij M. Towards Personalization in the Curative Treatment of Gastric Cancer. Front Oncol. 2020;10:614907. [PMID: 33330111 DOI: 10.3389/fonc.2020.614907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Phillips JD, Nagle AP, Soper NJ. Laparoscopic gastrectomy for cancer. Surg Oncol Clin N Am 2013;22:39-57, v-vi. [PMID: 23158084 DOI: 10.1016/j.soc.2012.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
104 Gretschel S, Bembenek A, Ulmer Ch, Hünerbein M, Markwardt J, Schneider U, Schlag PM. Prediction of gastric cancer lymph node status by sentinel lymph node biopsy and the Maruyama computer model. Eur J Surg Oncol. 2005;31:393-400. [PMID: 15837046 DOI: 10.1016/j.ejso.2004.11.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
105 Bando E, Kojima N, Kawamura T, Takahashi S, Fukushima N, Yonemura Y. Prognostic value of age and sex in early gastric cancer. Br J Surg. 2004;91:1197-1201. [PMID: 15449274 DOI: 10.1002/bjs.4541] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
106 Crookes PF, Incarbone R, Peters JH, Engle S, Bremner CG, Demeester TR. A selective therapeutic approach to gastric cancer in a large public hospital. The American Journal of Surgery 1995;170:602-5. [DOI: 10.1016/s0002-9610(99)80024-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
107 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
108 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
109 Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 1993;80:1153-1156. [PMID: 8402119 DOI: 10.1002/bjs.1800800930] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 3.2] [Reference Citation Analysis]
110 Hundahl SA, Wanebo HJ. Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol. 2005;31:605-615. [PMID: 16023944 DOI: 10.1016/j.ejso.2005.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
111 Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, Ruiz-Molina JM. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol 2000;7:210-7. [PMID: 10791852 DOI: 10.1007/BF02523656] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
112 de Bree E, Charalampakis V, Melissas J, Tsiftsis DD. The extent of lymph node dissection for gastric cancer: a critical appraisal. J Surg Oncol. 2010;102:552-562. [PMID: 20976727 DOI: 10.1002/jso.21646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
113 Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210:596-602. [PMID: 2818028 DOI: 10.1097/00000658-198911000-00005] [Cited by in Crossref: 305] [Cited by in F6Publishing: 266] [Article Influence: 9.2] [Reference Citation Analysis]
114 Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346-351. [PMID: 7796005 DOI: 10.1002/bjs.1800820321] [Cited by in Crossref: 261] [Cited by in F6Publishing: 248] [Article Influence: 9.7] [Reference Citation Analysis]
115 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
116 Mafune K. Surgery for Advanced Gastric Cancer. In: Kaminishi M, Takubo K, Mafune K, editors. The Diversity of Gastric Carcinoma. Tokyo: Springer-Verlag; 2005. pp. 271-86. [DOI: 10.1007/4-431-27713-7_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Bora H, Unsal D, Akmansu M. Results of chemoirradiation after curative resection of locally advanced gastric cancer. Int J Clin Pract 2004;58:451-6. [PMID: 15206500 DOI: 10.1111/j.1368-5031.2004.00024.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
118 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
119 Sue-Ling H. Radical D2 gastrectomy for cancer. The case of D2 resections. Ann R Coll Surg Engl 2007;89:672-4. [PMID: 17959003 DOI: 10.1308/003588407X209518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
120 Lawrence W Jr. Commentary: frequency of lymph node metastases to the splenic hilum. J Surg Oncol 2001;76:93-4. [PMID: 11223833 DOI: 10.1002/1096-9098(200102)76:2<93::aid-jso1017>3.0.co;2-i] [Reference Citation Analysis]
121 Cozzaglio L, Doci R, Celotti S, Roncalli M, Gennari L. Gastric Cancer: Extent of Lymph Node Dissection and Requirements for a Correct Staging. Tumori 2004;90:467-72. [DOI: 10.1177/030089160409000505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
122 Hundahl SA. Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest 2005;23:352-62. [PMID: 16100947 DOI: 10.1081/cnv-58885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Noguchi M, Miyazaki I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65. [DOI: 10.1002/(sici)1096-9098(199705)65:1<57::aid-jso12>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
124 Fox JG, Hunt PS. Management of acute bleeding gastric malignancy. Aust N Z J Surg. 1993;63:462-465. [PMID: 8498915 DOI: 10.1111/j.1445-2197.1993.tb00428.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
125 Korenaga D, Orita H, Okuyama T, Moriguchi S, Maehara Y, Sugimachi K. Quality of life after gastrectomy in patients with carcinoma of the stomach. Br J Surg 1992;79:248-50. [PMID: 1555093 DOI: 10.1002/bjs.1800790321] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 1.5] [Reference Citation Analysis]
126 Dent DM, Madden MV, Price SK. Controlled Trials and the R1/R2 Controversy in the Management of Gastric Carcinoma. Surgical Oncology Clinics of North America 1993;2:433-41. [DOI: 10.1016/s1055-3207(18)30565-9] [Cited by in Crossref: 19] [Article Influence: 0.7] [Reference Citation Analysis]
127 Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, Kakade AC, Hawaldar R. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg. 2006;23:192-197. [PMID: 16837811 DOI: 10.1159/000094537] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
128 Noshiro H, Nagai E, Shimizu S, Uchiyama A, Tanaka M. Laparoscopically assisted distal gastrectomy with standard radical lymph node dissection for gastric cancer. Surg Endosc 2005;19:1592-6. [PMID: 16247578 DOI: 10.1007/s00464-005-0175-9] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 6.4] [Reference Citation Analysis]
129 Hüscher C, Chiodini S, Freni V, Recher A, Torri F, Bozzetti F. Adequacy of paracardial dissection in subtotal versus total gastrectomy. British Journal of Surgery 1992;79:942-4. [DOI: 10.1002/bjs.1800790930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
130 Sawyers JL. Gastric carcinoma. Current Problems in Surgery 1995;32:101-78. [DOI: 10.1016/s0011-3840(05)80009-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
131 Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011;22 Suppl 5:v1-v9. [PMID: 21633049 DOI: 10.1093/annonc/mdr284] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
132 Melville A, Morris E, Forman D, Eastwood A. Management of upper gastrointestinal cancers. Qual Health Care 2001;10:57-64. [PMID: 11239144 DOI: 10.1136/qhc.10.1.57] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
133 Biondi A, Persiani R, Cananzi F, Zoccali M, Vigorita V, Tufo A, D’Ugo D. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010; 16(27): 3358-3370 [PMID: 20632437 DOI: 10.3748/wjg.v16.i27.3358] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
134 Sagar PM, Wedgwood KR, Benson EA. Surgery for gastric cancer. Lancet 1989;1:165. [PMID: 2463444 DOI: 10.1016/s0140-6736(89)91185-9] [Reference Citation Analysis]
135 Lawrence W. Extended surgery for gastric cancer: An historical commentary. Cancer 1998;82:429-32. [DOI: 10.1002/(sici)1097-0142(19980201)82:3<429::aid-cncr1>3.0.co;2-k] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
136 Martinez-monge R, Gerard JP, Kramling HJ, Guillemin F, Calvo FA. Gastric IORT With or Without EBRT. In: Gunderson LL, Willet CG, Harrison LB, Calvo FA, editors. Intraoperative Irradiation. Totowa: Humana Press; 1999. pp. 175-200. [DOI: 10.1007/978-1-59259-696-6_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
137 Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 2006;17 Suppl 6:vi13-8. [PMID: 16809641 DOI: 10.1093/annonc/mdl976] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
138 Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461. [PMID: 9790335 DOI: 10.1097/00000658-199810000-00002] [Cited by in Crossref: 762] [Cited by in F6Publishing: 697] [Article Influence: 31.8] [Reference Citation Analysis]
139 Tanigawa N, Shimomatsuya T, Horiuchi T, Masuda Y, Ihaya A, Chiba Y, Muraoka R. En bloc resection for cancer of the gastric cardia without thoracotomy. J Surg Oncol 1993;54:23-8. [DOI: 10.1002/jso.2930540108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Deng J, Liang H, Sun D, Zhang R, Zhan H, Wang X. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol. 2008;22:835-839. [PMID: 18925308 DOI: 10.1155/2008/761821] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
141 Kinoshita T, Maruyama K, Sasako M, Okajima K. Treatment Results of Gastric Cancer Patients: Japanese Experience. In: Nishi M, Ichikawa H, Nakajima T, Maruyama K, Tahara E, editors. Gastric Cancer. Tokyo: Springer Japan; 1993. pp. 319-30. [DOI: 10.1007/978-4-431-68328-5_23] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
142 Lustosa SA, Saconato H, Atallah AN, Lopes Filho Gde J, Matos D. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials. Acta Cir Bras. 2008;23:520-530. [PMID: 19030751 DOI: 10.1590/s0102-86502008000600009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
143 Dent DM. Cancer surgery: why some survival benefits may be artefactual. British Journal of Surgery 1998;85:433-4. [DOI: 10.1046/j.1365-2168.1998.00726.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
144 Tóth D, Kincses Z, Plósz J, Török M, Kovács I, Kiss C, Damjanovich L. Value of sentinel lymph node mapping using a blue dye-only method in gastric cancer: a single-center experience from North-East Hungary. Gastric Cancer. 2011;14:360-364. [PMID: 21538019 DOI: 10.1007/s10120-011-0048-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
145 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
146 Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today? The Oncologist 1998;3:171-7. [DOI: 10.1634/theoncologist.3-3-171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
147 Smalley SR, Gunderson L, Tepper J, Martenson JA, Minsky B, Willett C, Rich T. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52:283-293. [PMID: 11872272 DOI: 10.1016/s0360-3016(01)02646-3] [Cited by in Crossref: 125] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
148 de Manzoni G, Verlato G, Guglielmi A, Laterza E, Genna M, Cordiano C. Prognostic significance of lymph node dissection in gastric cancer. Br J Surg. 1996;83:1604-1607. [PMID: 9014687 DOI: 10.1002/bjs.1800831137] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 3.6] [Reference Citation Analysis]
149 Khushalani N. Cancer of the esophagus and stomach. Mayo Clin Proc. 2008;83:712-722. [PMID: 18533089 DOI: 10.4065/83.6.712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
150 Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol. 2007;46:277-285. [PMID: 17450463 DOI: 10.1080/02841860701218634] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
151 Ozmen MM, Zulfikaroglu B, Kucuk NO, Ozalp N, Aras G, Koseoglu T, Koç M. Lymphoscintigraphy in detection of the regional lymph node involvement in gastric cancer. Ann R Coll Surg Engl 2006;88:632-8. [PMID: 17132310 DOI: 10.1308/003588406X149200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
152 Adachi Y, Oshiro T, Mori M, Maehara Y, Sugimachi K. Prediction of early and late recurrence after curative resection for gastric carcinoma. Cancer 1996;77:2445-8. [PMID: 8640691 DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2445::AID-CNCR5>3.0.CO;2-L] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
153 Falcone A. Future strategies and adjuvant treatment of gastric cancer. Ann Oncol. 2003;14 Suppl 2:ii45-ii47. [PMID: 12810458 DOI: 10.1093/annonc/mdg729] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
154 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
155 Doekhie FS, Mesker WE, van Krieken JH, Kok NF, Hartgrink HH, Kranenbarg EK, Putter H, Kuppen PJ, Tanke HJ, Tollenaar RA. Clinical relevance of occult tumor cells in lymph nodes from gastric cancer patients. Am J Surg Pathol. 2005;29:1135-1144. [PMID: 16096401 DOI: 10.1097/01.pas.0000160439.38770.cb] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
156 Wu CW, Hsiung CA, Lo SS, Hsieh MC, Shia LT, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg. 2004;91:283-287. [PMID: 14991627 DOI: 10.1002/bjs.4433] [Cited by in Crossref: 111] [Cited by in F6Publishing: 106] [Article Influence: 6.2] [Reference Citation Analysis]
157 Feng JF, Huang Y, Liu J, Liu H, Sheng HY, Wei WT, Lu WS, Chen DF, Chen WY, Zhou XM. Risk factors for No. 12p and No. 12b lymph node metastases in advanced gastric cancer in China. Ups J Med Sci. 2013;118:9-15. [PMID: 23039019 DOI: 10.3109/03009734.2012.729103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
158 Sasagawa T, Solano H, Vega W, Mena F. The effectiveness of extended lymph node dissection for gastric cancer performed in Costa Rica under the supervision of a Japanese surgeon: a comparison with surgical results in Japan. Am J Surg. 2008;195:53-60. [PMID: 18082543 DOI: 10.1016/j.amjsurg.2007.01.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
159 Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS. Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit. Oncologist 2017;22:97-106. [PMID: 27789777 DOI: 10.1634/theoncologist.2016-0239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
160 Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of Western and Oriental trials. Cancer 1999;86:1657-68. [DOI: 10.1002/(sici)1097-0142(19991101)86:9<1657::aid-cncr6>3.0.co;2-j] [Cited by in Crossref: 37] [Article Influence: 1.6] [Reference Citation Analysis]
161 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
162 Roukos DH, Kappas AM, Encke A. Extensive lymph-node dissection in gastric cancer: is it of therapeutic value? Cancer Treatment Reviews 1996;22:247-52. [DOI: 10.1016/s0305-7372(96)90018-3] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
163 Hartgrink HH, van de Velde CJ. Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005;90:153-65. [DOI: 10.1002/jso.20222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
164 Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today. 2011;41:210-215. [PMID: 21264756 DOI: 10.1007/s00595-009-4251-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
165 McCulloch P, Nita ME, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2003;CD001964. [PMID: 14583942 DOI: 10.1002/14651858.cd001964.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
166 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237-2246. [PMID: 11147594 DOI: 10.1002/1097-0142(20001201)89:11%3C2237::AID-CNCR12%3E3.0.CO;2-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
167 Noguchi M, Miyazaki I. Management of lymph node metastases in breast cancer and gastric cancer. J Surg Oncol 1995;60:65-71. [DOI: 10.1002/jso.2930600113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
168 Bittner R, Butters M, Ulrich M, Uppenbrink S, Beger HG. Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg 1996;224:37-42. [PMID: 8678615 DOI: 10.1097/00000658-199607000-00006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 3.2] [Reference Citation Analysis]
169 Boddie AW Jr, McBride CM, Balch CM. Gastric cancer. Am J Surg 1989;157:595-606. [PMID: 2658642 DOI: 10.1016/0002-9610(89)90710-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 0.9] [Reference Citation Analysis]
170 Maruyama K, Gunvén P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210:596-602. [PMID: 2818028 DOI: 10.1007/bf02468883] [Cited by in Crossref: 931] [Cited by in F6Publishing: 188] [Article Influence: 28.2] [Reference Citation Analysis]
171 Yuan SQ, Chen YT, Huang ZP. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis. J Gastrointest Surg 2017;21:1591-8. [PMID: 28752402 DOI: 10.1007/s11605-017-3504-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
172 Hansson LE, Sparén P, Nyrén O. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg. 1999;230:162-169. [PMID: 10450729 DOI: 10.1097/00000658-199908000-00005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
173 Riall TS, Cameron JL, Lillemoe KD, Campbell KA, Sauter PK, Coleman J, Abrams RA, Laheru D, Hruban RH, Yeo CJ. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival. J Gastrointest Surg. 2005;9:1191-1204; discussion 1204-1206. [PMID: 16332474 DOI: 10.1016/j.gassur.2005.08.034] [Cited by in Crossref: 164] [Cited by in F6Publishing: 136] [Article Influence: 10.3] [Reference Citation Analysis]
174 Kong F, Qi Y, Liu H, Gao F, Yang P, Li Y, Jia Y. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis. Clin Transl Oncol 2015;17:917-24. [PMID: 26088414 DOI: 10.1007/s12094-015-1327-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
175 Robertson CS, Chung SC, Woods SD, Griffin SM, Raimes SA, Lau JT, Li AK. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-82. [PMID: 8053740 DOI: 10.1097/00000658-199408000-00009] [Cited by in Crossref: 248] [Cited by in F6Publishing: 210] [Article Influence: 8.9] [Reference Citation Analysis]
176 Shimoyama S, Seto Y, Yasuda H, Mafune K, Kaminishi M. Concepts, rationale, and current outcomes of less invasive surgical strategies for early gastric cancer: data from a quarter-century of experience in a single institution. World J Surg. 2005;29:58-65. [PMID: 15599744 DOI: 10.1007/s00268-004-7427-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
177 Kobayashi A, Nakagohri T, Konishi M, Inoue K, Takahashi S, Itou M, Sugitou M, Ono M, Saito N, Kinoshita T. Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg. 2004;8:464-470. [PMID: 15120372 DOI: 10.1016/j.gassur.2003.12.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
178 Lee WJ, Lee WC, Houng SJ, Shun CT, Houng RL, Lee PH, Chang KJ, Wei TC, Chen KM. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg. 1995;19:707-713. [PMID: 7571667 DOI: 10.1007/bf00295910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
179 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
180 Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol. 2004;30:20-25. [PMID: 14736518 DOI: 10.1016/j.ejso.2003.10.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
181 Vidal-Jove J, Sugarbaker PH. Surgical treatment of gastric cancer. Cancer Treat Res 1991;55:69-90. [PMID: 1718381 DOI: 10.1007/978-1-4615-3882-0_5] [Reference Citation Analysis]
182 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
183 Lise M, Nitti D, Marchet A, Sahmoud T, Duez N, Fornasiero A, dos Santos JG, Labianca R, Lasser P, Gignoux M. Prognostic factors in resectable gastric cancer: Results of EORTC study no. 40813 on FAM adjuvant chemotherapy. Annals of Surgical Oncology 1995;2:495-501. [DOI: 10.1007/bf02307082] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
184 Roukos D, Encke A. Effectiveness of extended lymphadenectomy in noncurative gastrectomy. The American Journal of Surgery 1996;172:303-4. [DOI: 10.1016/s0002-9610(96)00273-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
185 McCulloch P, Niita ME, Kazi H, Gama-Rodrigues JJ. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 2005;92:5-13. [PMID: 15635680 DOI: 10.1002/bjs.4839] [Cited by in Crossref: 79] [Cited by in F6Publishing: 70] [Article Influence: 4.6] [Reference Citation Analysis]
186 Taat CW, Van Lanschot JJB, Gouma DJ, Obertop H. Role of Extended Lymph Node Dissection in the Treatment of Gastrointestinal Tumours: A Review of the Literature. Scandinavian Journal of Gastroenterology 2009;30:109-16. [DOI: 10.3109/00365529509090309] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
187 Skoropad V, Berdov B, Zagrebin V. Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol. 2002;80:72-78. [PMID: 12173383 DOI: 10.1002/jso.10102] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
188 Shimoyama S, Yasuda H, Mafune K, Kaminishi M. Indications of a minimized scope of lymphadenectomy for submucosal gastric cancer. Ann Surg Oncol. 2002;9:625-631. [PMID: 12167575 DOI: 10.1007/BF02574477] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
189 Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14 Suppl 2:ii31-ii36. [PMID: 12810455 DOI: 10.1093/annonc/mdg726] [Cited by in Crossref: 217] [Cited by in F6Publishing: 231] [Article Influence: 11.4] [Reference Citation Analysis]
190 Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784. [PMID: 12374661 DOI: 10.1007/bf02574500] [Cited by in Crossref: 173] [Cited by in F6Publishing: 80] [Article Influence: 8.7] [Reference Citation Analysis]
191 Ballesta Lopez C, Ruggiero R, Poves I, Bettonica C, Procaccini E. The contribution of laparoscopy to the treatment of gastric cancer. Surg Endosc 2002;16:616-9. [PMID: 11972200 DOI: 10.1007/s00464-001-9022-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
192 Theuer CP, Al-kuran R, Akiyama Y, Okumura M, Ziogas A, Carpenter PM. Increased Epithelial Cadherin Expression among Japanese Intestinal-Type Gastric Cancers Compared with Specimens from American Patients of European Descent. The American Surgeon 2006;72:332-8. [DOI: 10.1177/000313480607200412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
193 Hundahl SA. Surgical quality control in gastric cancer trials. Surg Oncol Clin N Am 2002;11:445-58. [PMID: 12424862 DOI: 10.1016/s1055-3207(02)00014-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
194 Skoropad VY, Berdov BA, Mardynski YS, Titova LN. A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer. Eur J Surg Oncol. 2000;26:773-779. [PMID: 11087644 DOI: 10.1053/ejso.2000.1002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 2.9] [Reference Citation Analysis]
195 Marcenaro M, Foppiano F, Durzu S, Barra S, Corvò R. Kidney-Sparing Radiotherapy by Multiple-Field Three-Dimensional Technique in the Postoperative Management of Patients with Gastric Cancer: Comparison with Standard Two-Field Conformal Technique. Tumori 2006;92:34-40. [DOI: 10.1177/030089160609200107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
196 Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal vs total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg. 1999;230:170-178. [PMID: 10450730 DOI: 10.1097/00000658-199908000-00006] [Cited by in Crossref: 268] [Cited by in F6Publishing: 209] [Article Influence: 11.7] [Reference Citation Analysis]
197 Droste K, Bollschweiler E, Waschulzik T, Schütz T, Engelbrecht R, Maruyama K, Siewert JR. Prediction of lymph node metastasis in gastric cancer patients with neural networks. Cancer Lett. 1996;109:141-148. [PMID: 9020913 DOI: 10.1016/s0304-3835(96)04438-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
198 Macdonald JS. Advances in the therapy of gastric cancer. Gastric Cancer 2002;5 Suppl 1:35-40. [PMID: 12772886 DOI: 10.1007/s10120-002-0205-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
199 Theuer CP, Kurosaki T, Ziogas A, Butler J, Anton-culver H. Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates: High Survival Rates for Asians with Gastric Carcinoma. Cancer 2000;89:1883-92. [DOI: 10.1002/1097-0142(20001101)89:9<1883::aid-cncr3>3.0.co;2-h] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
200 Kochi M, Fujii M, Kanamori N, Kaiga T, Mihara Y, Funada T, Tamegai H, Takayama Y, Yoshida N, Takayama T. D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol. 2014;37:222-226. [PMID: 22892432 DOI: 10.1097/coc.0b013e31825eb734] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
201 Guadagni S, Catarci M, de Manzoni G, Kinoshita T. D1 versus D2 dissection for gastric cancer. Lancet 1995;345:1517; author reply 1517-8. [PMID: 7769935 [PMID: 7769935 DOI: 10.1016/s0140-6736(95)91078-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
202 Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15 Suppl 1:S60-S69. [PMID: 22138927 DOI: 10.1007/s10120-011-0110-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
203 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: Two open issues in gastric cancer. World J Gastroenterol 2014; 20(14): 3889-3904 [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
204 Herfarth C, Lehnert T. Invited commentary. World J Surg 1989;13:635-6. [DOI: 10.1007/bf01658890] [Reference Citation Analysis]
205 Athlin L, Lundskog B, Stenling R, Eriksson S. Local recurrence and long-term survival in patients with gastric cancer—Analysis of possible impact of clinicopathological parameters. European Journal of Surgical Oncology (EJSO) 1995;21:162-7. [DOI: 10.1016/s0748-7983(95)90336-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
206 Hundahl SA. Low maruyama index surgery for gastric cancer. Scand J Surg 2006;95:243-8. [PMID: 17249272 DOI: 10.1177/145749690609500406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
207 Lawrence W, Horsley Iii JS. Guest editorial: “EXTENDED” lymph node dissections for gastric cancer—Is more better? J Surg Oncol 1996;61:85-9. [DOI: 10.1002/(sici)1096-9098(199602)61:2<85::aid-jso1>3.0.co;2-n] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
208 Powell AG, Hughes DL, Wheat JR, Lewis WG. The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. International Journal of Surgery 2016;28:83-90. [DOI: 10.1016/j.ijsu.2016.02.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
209 Russell MC, Mansfield PF. Surgical approaches to gastric cancer. J Surg Oncol. 2013;107:250-258. [PMID: 22674546 DOI: 10.1002/jso.23180] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
210 Bonenkamp JJ, van de Velde CJ. Lymph node dissection in gastric cancer. Br J Surg. 1995;82:867-869. [PMID: 7648094 DOI: 10.1002/bjs.1800820703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
211 Carlomagno C, Matano E, Bianco R, Cimminiello C, Prudente A, Pagliarulo C, Crispo A, Cannella L, DE Stefano A, D'Armiento FP, DE Placido S. Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors. Exp Ther Med 2010;1:611-7. [PMID: 22993584 DOI: 10.3892/etm_00000096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
212 Liedman B, Andersson H, Berglund B, Bosaeus I, Hugosson I, Olbe L, Lundell L. Food intake after gastrectomy for gastric carcinoma: the role of a gastric reservoir. Br J Surg. 1996;83:1138-1143. [PMID: 8869329 DOI: 10.1002/bjs.1800830835] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
213 Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199-206. [PMID: 19142901 DOI: 10.1002/jso.21224] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
214 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
215 Kodera Y, Schwarz RE, Nakao A. Extended lymph node dissection in gastric carcinoma. Journal of the American College of Surgeons 2002;195:855-64. [DOI: 10.1016/s1072-7515(02)01496-5] [Cited by in Crossref: 57] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
216 Dikken JL, Cats A, Verheij M, van de Velde CJ. Randomized trials and quality assurance in gastric cancer surgery: Randomized Trials and Quality Assurance. J Surg Oncol 2013;107:298-305. [DOI: 10.1002/jso.23080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
217 Agboola O. Adjuvant treatment in gastric cancer. Cancer Treat Rev. 1994;20:217-240. [PMID: 8020004 DOI: 10.1016/0305-7372(94)90001-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
218 Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253:900-911. [PMID: 21394009 DOI: 10.1097/sla.0b013e318212bff6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
219 Shriver CD, Karpeh M, Brennan MF. Extended Lymph Node Dissection in Gastric Cancer. Surgical Oncology Clinics of North America 1993;2:393-411. [DOI: 10.1016/s1055-3207(18)30563-5] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
220 Arcangeli G, Saracino B, Arcangeli G, Angelini F, Marchetti P, Tirindelli Danesi D. Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer. International Journal of Radiation Oncology*Biology*Physics 2002;54:1069-75. [DOI: 10.1016/s0360-3016(02)03026-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
221 Rohde H, Gebbensleben B, Bauer P, Stützer H, Zieschang J. Has there been any improvement in the staging of gastric cancer? Findings from the German Gastric Cancer TNM Study Group. Cancer 1989;64:2465-81. [PMID: 2684385 DOI: 10.1002/1097-0142(19891215)64:12<2465::aid-cncr2820641212>3.0.co;2-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
222 Matsuo K, Shimura H, Tanaka S, Nakano M, Hashimoto T, Kojima D, Yamashita Y, Inoue K, Satoh H, Inoue A. Laparoscopic distal gastrectomy with intracorporeal handsewn Billroth-I anastomosis (ICHSA). Surg Endosc 2012;26:2981-7. [DOI: 10.1007/s00464-011-2107-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
223 Coquard R, Ayzac L, Gilly FN, Rocher FP, Romestaing P, Sentenac I, Francois Y, Vignal J, Braillon G, Gerard JP. Intraoperative radiation therapy combined with limited lymph node resection in gastric cancer: an alternative to extended dissection. Int J Radiat Oncol Biol Phys. 1997;39:1093-1098. [PMID: 9392549 DOI: 10.1016/s0360-3016(97)00386-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
224 Roukos D, Kappas AM, Encke A. Effectiveness of extended lymphadenectomy in early gastric cancer. Surgery 1996;119:238-9. [DOI: 10.1016/s0039-6060(96)80179-6] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
225 Meszoely IM, Chapman WC, Holzman MD, Leach SD. New trends in gastrointestinal surgical oncology. Cancer Treat Res 1998;98:239-91. [PMID: 10326672 DOI: 10.1007/978-1-4615-4977-2_10] [Reference Citation Analysis]
226 Lardenoye JWH, Kappetein AP, Lagaay MB, Allema JH, Breslau PJ. Survival of proximal third gastric carcinoma. J Surg Oncol 1998;68:183-6. [DOI: 10.1002/(sici)1096-9098(199807)68:3<183::aid-jso10>3.0.co;2-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
227 Sakar B, Karagol H, Gumus M, Basaran M, Kaytan E, Argon A, Ustuner Z, Bavbek SE, Bugra D, Aykan FN. Timing of Death From Tumor Recurrence After Curative Gastrectomy for Gastric Cancer: . American Journal of Clinical Oncology 2004;27:205-9. [DOI: 10.1097/01.coc.0000092703.12189.a2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
228 van Lanschot JJB, Tilanus HW, Voormolen MHJ, van Deelen RAJ. Recurrence pattern of oesophageal carcinoma after limited resection does not support wide local excision with extensive lymph node dissection. British Journal of Surgery 1994;81:1320-3. [DOI: 10.1002/bjs.1800810921] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
229 Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, Kim S, Noh JH, Joh JW, Choi SH, Sohn TS, Heo JS, Park CH, Park JO, Lee JE, Park YJ, Nam HR, Park W, Ahn YC, Huh SJ. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view. Br J Cancer 2004;91:11-7. [PMID: 15162146 DOI: 10.1038/sj.bjc.6601896] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.0] [Reference Citation Analysis]
230 Miwa K, Miyazaki I, Sahara H, Fujimura T, Yonemura Y, Noguchi M, Falla R. Rationale for extensive lymphadenectomy in early gastric carcinoma. Br J Cancer. 1995;72:1518-1524. [PMID: 8519670 DOI: 10.1038/bjc.1995.540] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.1] [Reference Citation Analysis]
231 McCulloch P. Gastric cancer. Postgrad Med J 1996;72:450-7. [PMID: 8796206 DOI: 10.1136/pgmj.72.850.450] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
232 Sendler A. [Tumors of the upper gastro-intestinal tract]. Chirurg 2010;81:103-6; 108-10. [PMID: 20076935 DOI: 10.1007/s00104-009-1813-x] [Reference Citation Analysis]
233 Bonenkamp J, Bunt A, van de Velde C, Sasako M, Boon M. Radical Lymphadenectomy for Gastric Cancer: A Prospective Randomized Trial in the Netherlands. Surgical Oncology Clinics of North America 1993;2:443-58. [DOI: 10.1016/s1055-3207(18)30566-0] [Cited by in Crossref: 10] [Article Influence: 0.3] [Reference Citation Analysis]
234 Orditura M, Martinelli E, Galizia G, Vitiello F, Fasano M, Muto P, Ciardiello F, De Vita F. Chemoradiotherapy as adjuvant treatment of gastric cancer. Ann Oncol 2007;18 Suppl 6:vi133-5. [PMID: 17591807 DOI: 10.1093/annonc/mdm242] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
235 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States?: A comparison of patient survival among three institutions. Cancer 2000;89:2237-46. [DOI: 10.1002/1097-0142(20001201)89:11<2237::aid-cncr12>3.0.co;2-9] [Cited by in Crossref: 120] [Article Influence: 5.5] [Reference Citation Analysis]
236 Tóth D, Török M, Kincses Z, Damjanovich L. Prospective, comparative study for the evaluation of lymph node involvement in gastric cancer: Maruyama computer program versus sentinel lymph node biopsy. Gastric Cancer. 2013;16:201-207. [PMID: 22740059 DOI: 10.1007/s10120-012-0170-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
237 Meyer HJ. The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol. 2005;31:595-604. [PMID: 15919174 DOI: 10.1016/j.ejso.2005.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
238 Díaz de Liaño A, Yarnoz C, Aguilar R, Artieda C, Ortiz H. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer. Gastric Cancer 2008;11:96-102. [PMID: 18595016 DOI: 10.1007/s10120-008-0460-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
239 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
240 Vadthya G, Ramakrishnaiah VPN, Krishnamachari S. Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach. Indian J Surg Oncol 2017;8:304-11. [DOI: 10.1007/s13193-017-0620-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
241 Disiena MR, Taneja C, Wanebo HJ. Radical Gastrectomy and Lymphadenectomy: Historic Overview, Surgical Trends, and Lessons from the Past. Surgical Oncology Clinics of North America 2005;14:511-32. [DOI: 10.1016/j.soc.2005.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
242 Roukos D, Schmidt-Mathiesen A, Encke A. Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surg Oncol 1995;4:323-32. [PMID: 8809955 DOI: 10.1016/s0960-7404(10)80045-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
243 Natarajan S, Taneja C, Cady B. Evolution of Lymphadenectomy in Surgical Oncology. Surgical Oncology Clinics of North America 2005;14:447-59. [DOI: 10.1016/j.soc.2005.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
244 Ozmen MM, Ozmen F, Zulfikaroglu B. Lymph nodes in gastric cancer. J Surg Oncol 2008;98:476-81. [DOI: 10.1002/jso.21134] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
245 Noguchi M, Miyazakit I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer: LYMPH NODE METASTASIS IN GASTRIC CANCER. Br J Surg 1996;83:156-61. [DOI: 10.1046/j.1365-2168.1996.02183.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
246 Hartgrink HH, Bonenkamp HJ, van de Velde CJ. Influence of Surgery on Outcomes in Gastric Cancer. Surgical Oncology Clinics of North America 2000;9:97-117. [DOI: 10.1016/s1055-3207(18)30171-6] [Cited by in Crossref: 24] [Article Influence: 1.1] [Reference Citation Analysis]
247 Peeters K, van de Velde C. Quality assurance of surgery in gastric and rectal cancer. Critical Reviews in Oncology/Hematology 2004;51:105-19. [DOI: 10.1016/j.critrevonc.2004.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
248 Lim DH. Postoperative adjuvant radiotherapy for patients with gastric adenocarcinoma. J Gastric Cancer 2012;12:205-9. [PMID: 23346491 DOI: 10.5230/jgc.2012.12.4.205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
249 Ozmen MM, Zulfikaroglu B, Ozmen F, Moran M, Ozalp N, Seckin S. D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer. Turk J Surg 2021;37:49-58. [PMID: 34585094 DOI: 10.47717/turkjsurg.2020.4931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Tóth D, Kathy S, Csobán T, Kincses Z, Török M, Plósz J, Damjanovich L. [Prospective comparative study of sentinel lymph node mapping in gastric cancer -- submucosal versus subserosal marking method]. Magy Seb. 2012;65:3-8. [PMID: 22343099 DOI: 10.1556/maseb.65.2012.1.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
251 McLoughlin JM. Adenocarcinoma of the stomach: a review. Proc (Bayl Univ Med Cent) 2004;17:391-9. [PMID: 16200126 DOI: 10.1080/08998280.2004.11928001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
252 Eom BW, Joo J, Kim Y, Park B, Park JY, Yoon HM, Lee JH, Ryu KW. Is There Any Role of Additional Retropancreatic Lymph Node Dissection on D2 Gastrectomy for Advanced Gastric Cancer? Ann Surg Oncol 2013;20:2669-75. [DOI: 10.1245/s10434-013-2938-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
253 Yamamoto M, Rashid OM, Wong J. Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol. 2015;6:79-88. [PMID: 25642341 DOI: 10.3978/j.issn.2078-6891.2014.097] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
254 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
255 Carboni M, Guadagni S, Catarci M, Gossetti F, Negro P. Surgical Treatment of Gastric Cancer: Our Elective Procedures for Desirable Curability. In: Reed PI, Carboni M, Johnston BJ, Guadagni S, editors. New Trends in Gastric Cancer. Dordrecht: Springer Netherlands; 1990. pp. 135-50. [DOI: 10.1007/978-94-009-2167-2_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
256 Pata G, Solaini L, Roncali S, Pasini M, Ragni F. Total gastrectomy with “over-D1” lymph node dissection: what is the actual impact of age? The American Journal of Surgery 2012;204:732-40. [DOI: 10.1016/j.amjsurg.2012.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
257 Leong T, Michael M, Foo K, Thompson A, Lim Joon D, Weih L, Ngan S, Thomas R, Zalcberg J. Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation. Br J Cancer. 2003;89:1433-1438. [PMID: 14562013 DOI: 10.1038/sj.bjc.6601311] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
258 Van Cutsem E, Van de Velde C, Roth A, Lordick F, Köhne CH, Cascinu S, Aapro M. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group. Eur J Cancer. 2008;44:182-194. [PMID: 18093827 DOI: 10.1016/j.ejca.2007.11.001] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
259 Beamish AJ, Chan DS, Blake PA, Karran A, Lewis WG. Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery. Int J Surg. 2015;19:46-54. [PMID: 26004350 DOI: 10.1016/j.ijsu.2015.05.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
260 Díaz de Liaño A, Yárnoz C, Aguilar R, Artieda C, Ortiz H. [Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit]. Cir Esp 2008;83:18-23. [PMID: 18208744 DOI: 10.1016/s0009-739x(08)70491-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
261 Jiang L, Yang K, Chen Y, Guan Q, Zhao P, Tian J, Wang Q. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. British Journal of Surgery 2014;101:595-604. [DOI: 10.1002/bjs.9497] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]